Clinical Trial Update: (Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating alkaline phosphatase for sepsis-associated acute kidney injury was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis

Drugs mentioned

• Alkaline Phosphatase (alkaline phosphatase)

Snippet

Sponsor: AM-Pharma | Conditions: Acute Kidney Injury Due to Sepsis | Phase 3 | Status: TERMINATED | Results posted: 2024-06-03